Main Menu    Home Page    Registration    Accommodation    Program    General Information    Organisation    Contact

Treatment Options in Phenylketonuria and Related Pediatric Neurotransmitter Disorders Treatment Options in Phenylketonuria and Related Pediatric Neurotransmitter Disorders August 29, 2009 - San Diego - California Symposium Schedule   Scientific Sessions Saturday, August 29 8:00 Registration Open   9:00-12:00 Morning session Challenges in the pharmaceutical treatment of PKU; benefits and pitfalls Chair: Barbara Burton 09:00-09:30     Assessing psychological benefits of new treatments for PKU - Susan Waisbren (USA) 09:30-10:00     Treatment of patients with PKU with BH4 - Alberto Burlina (Italy) 10:00-10:30     Combining BH4 and dietary therapy in patients with PKU - Rani H. Singh (USA) Coffee 10:00-11:30     The safety profile of BH4 in clinical practice - Amaya Bélanger-Quintana (Spain) 11:30-12:00     Pitfalls in determining BH4 responsiveness and in treating patients with BH4 - Barbara Burton (USA)   Lunch break   13:00—16:00 Afternoon session Treatment of pediatric neurotransmitter disorders Chair: Nenad Blau 13:00-13:30     Tyrosine hydroxylase deficiency - Georg Hoffmann (Germany) 13:30-14:00     Aromatic AA decarboxylase deficiency - Wang Tso Lee (Taiwan) 14:00-14:30     Tetrahydrobiopterin deficiencies - Nenad Blau (CH) Coffee 15:00-15:30     Dopa-responsive dystonia (GTPCH def.) - Kathy Swoboda (USA) 15:30-16:00     Sepiapterin reductase deficiency - Jennifer Friedman (USA) 15:00 – 17:00 ICIEM Registration Open 18:30 ICIEM Opening Welcome Reception

Treatment Options in Phenylketonuria and Related Pediatric Neurotransmitter Disorders :: August 29 2009